Is prehypertension a risk factor for cardiovascular diseases?

Stroke

Volumn 36, Issue 9, 2005, Pages 1859-1863

  Qureshi, Adnan I ^a,c   Suri, M Fareed K ^a   Kirmani, Jawad F ^a   Divani, Afshin A ^a   Mohammad, Yousef ^b  

^a INSTITUTE OF OPHTHALMOLOGY AND VISUAL SCIENCE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c NEUROLOGICAL INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Cardiovascular diseases; Cerebrovascular disorders; Myocardial infarction; Stroke

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; STROKE;

ADULT; AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; CORONARY ARTERIOSCLEROSIS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RISK; RISK FACTORS; SMOKING; TIME FACTORS; TREATMENT OUTCOME;

EID: 24644478073     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000177495.45580.f1     Document Type: Article

References (23)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wight JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. J Am Med Assoc. 2003;289:2560-2572.
2. Joint National Committee on Prevention Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
3. Dawber TR, Meadors GF, Moore FE. Epidemiologic approaches to heart disease: the Framingham Study. Am J Public Health. 1951;41:279-286.
4. Kannel WB, Wolf PA, Garrison RJ, eds. Section 34: Some Risk Factors Related to the Annual Incidence of Cardiovascular Disease and Death in Pooled Repeated Biennial Measurements: Framingham Mean Study, 30-Year Follow-Up. Bethesda, Md: US Department of Health and Human Services; 1987.
5. Wolf PA, D'Agostino RB. Epidemiology of stroke. In: Barnett HJM, Mohr JP, Stein BM, Yatsu F, eds. Stroke: Pathophysiology, Diagnosis, and Management. 3rd ed. New York: Churchill Livingstone; 1998:6-7.
6. Brand FN, Larson M, Friedman LM, Kannel WB, Castelli WP. Epidemiologic assessment of angina before and after myocardial infarction: the Framingham Study. Am Heart J. 1996;132:174-178.
7. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162:1867-1872.
8. Cupples LA, D'Agostino RB, Anderson K, Kannel WB. Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med. 1988;7:205-222.
9. Hennekens CH, Buring JE. Epidemiology in Medicine. 1st ed. Boston: Little, Brown, and Co; 1987.
10. Qureshi AI, Suri MFK, Mohammad Y, Guterman LR, Hopkins LN. Isolated and borderline isolated systolic hypertension relative to long-term risk and type of stroke: a 20-year follow-up of the National Health and Nutrition Survey. Stroke. 2002;33:2781-2788.
11. O'Donnell CJ, Ridker PM, Glynn RJ, Berger K, Ajani U, Manson JE, Hennekens CH. Hypertension and borderline isolated systolic hypertension increase the risks of cardiovascular disease and mortality in male physicians. Circulation. 1997;95:1132-1137.
12. Trenkwalder P, Hendricks P, Schoniger R. Rossberg J, Lydtin H, Hense HW. Hypertension as a risk factor for cardiovascular morbidity and mortality in an elderly German population: the prospective STEPHY II study Starnberg Study on Epidemiology of Parkinsonism and Hypertension in the Elderly. Eur Heart J. 1999;20:1752-1756.
13. Casiglia E, Mazza A, Tikhonoff V, Pavei G, Private G, Schenal N, Pesina AC. Weak effect of hypertension and other classic risk factors in the elderly who have already paid their toll. J Hum Hypertens. 2002;16: 21-31.
14. Takishita S, Abe I, Kobayashi K, Takata Y, Eto T, Fukiyama K, Kojima K. Insulin and cardiovascular diseases in Japanese work-site population with borderline to mild hypertension. Hypertens Res. 1996;19:S13-S18.
15. Lonati L, Cuspidi C, Sampieri L, Boselli L, Bocciolone M, Leonetti G, Zanchetti A. Ultrasonographic evaluation of cardiac and vascular changes in young borderline hypertensives. Cardiology. 1993;83:298-303.
16. Escudero E, De Lena S, Graff-Iversen S, Almiron M, Cingolani HE. Left ventricular diastolic function in young men with high normal blood pressure. Can J Cardiol. 1996;12:959-964.
17. Kimura Y, Tomiyama H, Nishikawa E, Watanabe G, Shiojima K, Nakayama T, Yoshida H, Kuwata S, Kinouchi T, Doba N. Characteristics of cardiovascular morphology and function in the high-normal subset of hypertension defined by JNC-VI recommendations. Hypertens Res. 1999; 22:291-295.
18. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Eng J Med. 2001;345:1291-1297.
19. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
20. Macera CA, Powell KE. Population-attributable risk: implications of physical activity dose. Med Sci Sports Exercise. 2001;33:S635-S639.
21. Suarez C How should we treat hypertensive women with cardiac and renal impairment? Am J Hypertens. 1997;10:242S-246S.
22. Snow V. Weiss KB. Mottur-Pilson C. Clinical Efficacy Assessment Subcommittee of the American College of Physicians. The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus. Ann Intern Med. 2003;138:587-592.
23. Staessen JA, Asmar R, De Buyzere M, Imai Y, Parati G, Shimada K, Stergiou G, Redon J, Verdecchia P; Participants of the 2001 Consensus Conference on Ambulatory Blood Pressure Monitoring. Task Force II: blood pressure measurement and cardiovascular outcome. Blood Press Monit. 2001;6:355-370.